Joao J. Cerqueira
Braga, 4710243, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Sensor-Based Classification of Post-Stroke Motor Impairment Using Fugl-Meyer Lower Extremity Scores.
Sensor-Based Classification of Post-Stroke Motor Impairment Using Fugl-Meyer Lower Extremity Scores.
Journal: Sensors (Basel, Switzerland)
Published: May 13, 2026
Task-Dependent Performance of Wearable Multimodal Biofeedback in Physical Rehabilitation: A Longitudinal Post-Stroke Case Study.
Journal: Healthcare (Basel, Switzerland)
Published: April 27, 2026
Correction: Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study.
Journal: Journal of neurology
Published: November 18, 2025
Social memory deficits and their neural correlates in multiple sclerosis.
Journal: Scientific reports
Published: June 16, 2025
Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS: Nine-Year Data From the OPERA Studies Open-Label Extension.
Journal: Neurology
Published: January 30, 2025
Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study.
Journal: Journal of neurology
Published: November 25, 2024
Corrigendum to "Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis" [Int. Immunopharmacol. 131 (2024) 111826].
Journal: International immunopharmacology
Published: November 05, 2024
Multiple Sclerosis Disease-Modifying Treatment Algorithms: 2025 Positioning of the Portuguese Multiple Sclerosis Study Group.
Journal: Acta medica portuguesa
Published: October 01, 2024
Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis.
Journal: International immunopharmacology
Published: December 01, 2023
Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model.
Journal: Cells
Published: September 05, 2023
One-year regional brain volume changes as potential predictors of cognitive function in multiple sclerosis: a pilot study.
Journal: Irish journal of medical science
Published: August 17, 2023
Last Updated: 09/26/2026